Javascript is not enabled.

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again.

Skip to content
Content starts here
Leaving Website

You are now leaving and going to a website that is not operated by AARP. A different privacy policy and terms of service will apply.

More Eye Drops Recalled Due to Contamination Risk

Products used to treat ocular inflammation, glaucoma

spinner image a bottle of eye drops and a dropper
Getty Images

Two more brands of eye drops have been recalled due to contamination risks that could cause adverse reactions, including eye infections that could lead to blindness.

The Food and Drug Administration (FDA) issued recall notices for eye drop manufacturers Pharmedica and Apotex, citing contamination concerns. In February, EzriCare Artificial Tears were recalled after being linked to antibiotic-resistant infections. At least 55 cases were reported, which resulted in vision loss, hospitalization and one death.

spinner image Image Alt Attribute

AARP Membership— $12 for your first year when you sign up for Automatic Renewal

Get instant access to members-only products and hundreds of discounts, a free second membership, and a subscription to AARP the Magazine.

Join Now

Two lots of Pharmedica’s Purely Soothing 15% MSM Drops, used to treat eye inflammation and irritation, were recalled due to non-sterility. The products were sold worldwide at trade shows and at online retailers, including Pharmedica advises consumers to immediately stop using the recalled products and return them to the place of purchase. Questions can be directed to the company by phoning 623-698-1752 from 8 a.m. to 5 p.m. MT or by email to

The recalled batches include lot #2203PS01, sold in a 1-ounce bottle, and lot #1808051, sold in half-ounce bottles.

Apotex pulled six lots of its Brimonidine Tartrate Ophthalmic Solution, 0.15% because the bottle caps may be cracked, causing the solution to become unsterile. The product is used by patients with open-angle glaucoma or ocular hypertension. Patients who purchased the recalled lots should contact their pharmacy and their health care provider for medical advice. The drops may be returned to Inmar Rx Solutions by calling 855-275-1273 from 9 a.m. to 5 p.m. ET.

The affected lot numbers are TJ9848 and TJ9849 with an expiration date of February 2024, and TK0258, TK5341, TK0261 and TK0262 with an April 2024 expiration date.

spinner image packages for two types of eyedrops that have been recalled in March 2023
A bottle of Apotex Brimonidine Tartrate Ophthalmic Solution (left) and packaging for Pharmedica Purely Soothing eye drops (right), both recalled in March 2023
Getty Images

There have been no reports of injury or adverse events related to either of the newly recalled eye drops. There are no known connections to the February recall of Ezricare Artificial Tears.

Adverse reactions or quality problems from the use of these products may be reported to the FDA’s MedWatch adverse event reporting program, online, by regular mail or by calling 800-332-1088.​

Discover AARP Members Only Access

Join AARP to Continue

Already a Member?